$202.34
8.79%
Nasdaq, Nov 16, 04:28 pm EST. Closed.
Why the stock moved Why the stock moved

Astera Labs Target price 2026 - Analyst rating & recommendation

Astera Labs Classifications & Recommendation

Buy
69%
Hold
31%

Astera Labs Price Target

Target Price $433.50
Price $202.34
Potential 114.24%
Number of Estimates 23
23 Analysts have issued a price target Astera Labs 2027 . The average Astera Labs target price is $433.50. This is 114.24% higher than the current stock price. The highest price target is $525.00 159.46% , the lowest is $257.55 27.29% .
A rating was issued by 29 analysts: 20 Analysts recommend Astera Labs to buy, 9 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Astera Labs stock has an average upside potential 2027 of 114.24% . Most analysts recommend the Astera Labs stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion $ ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

28 Analysts have issued a sales forecast Astera Labs 2026 . The average Astera Labs sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 $853m 115.13%
2026
2027
2028
2029
2030

15 Analysts have issued an Astera Labs EBITDA forecast 2026. The average Astera Labs EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $180m 259.64%
2026
2027
2028
2029

EBITDA Margin

2025 21.14% 174.21%
2026
2027
2028
2029

27 Astera Labs Analysts have issued a net profit forecast 2026. The average Astera Labs net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $219m 362.68%
2026
2027
2028
2029

Net Margin

2025 25.70% 222.11%
2026
2027
2028
2029

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share $ ??? ???
??? ???
P/E ???
EV/Sales ???

27 Analysts have issued a Astera Labs forecast for earnings per share. The average Astera Labs EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $1.22 290.63%
2026
2027
2028
2029

P/E ratio

Current 80.29 38.81%
2026
2027
2028
2029

Based on analysts' sales estimates for 2026, the Astera Labs stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 21.84 32.07%
2026
2027
2028
2029
2030

P/S ratio

Current 22.72 32.60%
2026
2027
2028
2029
2030

Current Astera Labs Upgrades & Downgrades

Analyst Rating Action Date
BMO Capital
➜
Outperform
Initiated Nov 05 2026
TD Cowen
Hold
➜
Hold
Unchanged Nov 04 2026
Morgan Stanley
Overweight
➜
Overweight
Unchanged Nov 04 2026
Evercore ISI Group
Outperform
➜
Outperform
Unchanged Nov 04 2026
Susquehanna
Neutral
➜
Neutral
Unchanged Nov 04 2026
RBC Capital
Outperform
➜
Outperform
Unchanged Nov 04 2026
Needham
Buy
➜
Buy
Unchanged Nov 04 2026
Analyst Rating Date
Initiated
BMO Capital:
➜
Outperform
Nov 05 2026
Unchanged
TD Cowen:
Hold
➜
Hold
Nov 04 2026
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
Nov 04 2026
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
Nov 04 2026
Unchanged
Susquehanna:
Neutral
➜
Neutral
Nov 04 2026
Unchanged
RBC Capital:
Outperform
➜
Outperform
Nov 04 2026
Unchanged
Needham:
Buy
➜
Buy
Nov 04 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today